rh lactoferrin (Santen)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namerh lactoferrin (Santen)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLactotransferrin stimulants
TargetsLactotransferrin
Therapy Area/IndicationsCorneal DiseasesXerophthalmiaConjunctival Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAgennix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCorneal DiseasesXerophthalmiaConjunctival Diseases

Other Information

ATC CodeN/A
Related LinksN/A